Cargando…

A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan

The incidence rate of AL (light-chain) amyloidosis is not known in Asia. We conducted a retrospective cohort study using the Taiwan National Healthcare Insurance Research database and Death Registry to estimate incidence and all-cause case fatality rates, and characteristics of patients with AL amyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Hsin-An, Tang, Chao-Hsiun, Goh, Choo Hua, Shen, Shih-Pei, Huang, Kuan-Chih, Qiu, Hong, Siggins, Sarah, Rothwell, Lee Anne, Liu, Yanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492671/ https://www.ncbi.nlm.nih.gov/pubmed/36131079 http://dx.doi.org/10.1038/s41598-022-18990-3

Ejemplares similares

Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2021)

Treatment evolution and improved survival in multiple myeloma in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2021)

The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan
por: Herr, Keira Joann, et al.
Publicado: (2023)

Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2020)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022)

Healthcare resource utilization and costs associated with generalized myasthenia gravis: a retrospective matched cohort study using the National Health Insurance Research Database in Taiwan
por: Shen, Shih-Pei, et al.
Publicado: (2023)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study
por: Huang, Yu-Huei, et al.
Publicado: (2022)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
por: Qian, Min, et al.
Publicado: (2021)

Localized Lymph Node Light Chain Amyloidosis
por: Dhakal, Binod, et al.
Publicado: (2015)

Importance of FISH genetics in light chain amyloidosis
por: Gertz, Morie A., et al.
Publicado: (2017)

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Kappa light-chain amyloidosis of gastrointestinal tract
por: Hashimoto, Rintaro, et al.
Publicado: (2019)

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

Localized Lymph Node Light Chain Amyloidosis
por: Yamamoto, Akira, et al.
Publicado: (2020)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Light chain amyloidosis presenting as retiform purpura
por: Soliman, Yssra S., et al.
Publicado: (2021)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

COVID-19 and Light Chain Amyloidosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
por: Lohani, Sadichhya, et al.
Publicado: (2016)

Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina
por: Posadas-Martinez, Maria Lourdes, et al.
Publicado: (2022)

Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
por: Rao, Rohit R., et al.
Publicado: (2016)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
por: Venkatesh, Sudhakar K., et al.
Publicado: (2019)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019)

Electrocardiographic parameters and prognosis of renal light chain amyloidosis
por: Li, Huixian, et al.
Publicado: (2020)

Facial Paralysis as Initial Manifestation of Light-chain Amyloidosis
por: Martins, André M, et al.
Publicado: (2019)

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
por: Kaufman, Gregory P., et al.
Publicado: (2021)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
por: Morisaki, Shinsuke, et al.
Publicado: (2021)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
por: Stelmach-Gołdyś, Agnieszka, et al.
Publicado: (2022)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

Raccoon Eye Sign in Amyloid Light-chain Amyloidosis
por: Mizuno, Shinichi
Publicado: (2022)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f6lvfd7tis6m6dvsafbgcs5vcn